Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data
about
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-AnalysisThe utility of neuroimaging in the differential diagnosis of parkinsonian syndromesA systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismSurrogate outcomes in neurology, psychiatry, and psychopharmacologyNeuroimaging in Parkinson disease: from research setting to clinical practice.Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.The pathophysiology of parkinsonism in multiple system atrophy.Kinetic analysis of dynamic (11)C-acetate PET/CT imaging as a potential method for differentiation of hepatocellular carcinoma and benign liver lesions.Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismApplications of positron emission tomography (PET) in neurology.Evidence from biomarkers and surrogate endpoints.Imaging the head: functional imaging.Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans.Proposed neuroimaging criteria for the diagnosis of multiple system atrophy.Rational therapeutic approaches to progressive supranuclear palsy.PET/CT in diagnosis of movement disorders.Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.Dopaminergic imaging: clinical utility now and in the future.Positron emission tomography imaging in neurological disorders.Fifty years of progressive supranuclear palsy.Positron emission tomography in the differential diagnosis of parkinsonism.Role of (18) F-FDOPA PET/CT imaging in endocrinology.Imaging synucleinopathies.[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.Brain positron emission tomography with 2-18F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders.Inappropriate crying and laughing in Parkinson disease and movement disorders.[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.Can imaging separate multiple system atrophy from Parkinson's disease?
P2860
Q24282619-F31F78C2-6AD2-4B95-B677-89A2EA05D5ABQ27025731-671EC02F-5FB2-4828-B27D-58F364CB160EQ28075227-E2F5ADC0-1CDF-4BDE-918A-62E6C2C5FE70Q30473416-5122D94C-98C8-43E7-B08A-94A19282B746Q30868628-44FD8226-D453-4901-9C71-5AFA5E47B4D7Q31388180-EB9442A8-A863-4CCC-A7FA-B7349F8EF503Q33735302-36A706AB-C510-4CDB-8EC6-71166967C5B4Q35055565-CFEEF0B2-AB6E-4DEC-9BEC-DF73E9ABE363Q35086511-2E28076F-9897-498E-A17F-56F851A880C1Q35455565-C80149F1-E196-491D-AA68-9C8FFF2BDF8CQ35748290-355AB77B-A8F1-40E4-B76F-CC394B5E390DQ36045330-B85967FA-8CEF-4088-9F72-F79FB392CFEBQ36718204-60539DB4-F771-4A1D-9795-CB4A6F3346DFQ36905656-A2F87A3F-5D98-4EC5-BC95-DDF8550795F6Q37106123-C9EDF381-A624-4FC9-86A7-4D9B3BFB2A7DQ37420656-8EFC5509-53BC-466C-A114-F72FFE80F07AQ37753509-ADB32DA3-4BFE-48A2-9663-248EB88CFFB9Q37896142-4DB4C7A6-1A2A-4F59-8197-5D82AD31AEC1Q37906364-47D8BD2D-952E-4A27-B7BE-C87317F00A57Q37910636-CA3C4371-16C6-4FF8-ACF5-D805E65FE718Q37917854-21445E33-3A47-429F-BA04-B39999887019Q37980609-855EB1B7-2D3B-470D-B90C-FBC1A064BF27Q38135221-1CAA2393-C3A3-466F-9DB9-09880E29C9E0Q38215508-E2A713D3-406C-44E0-883D-4D24DFCD5395Q38233342-72628E5A-0674-4AAF-B160-5BFB38A97897Q38734660-F9C96AE2-B380-4B3A-A749-CF2BA046C65FQ43827115-B94C7944-C259-403F-8814-D1444F1D9AD3Q43938517-59387A9F-734F-428C-A6B8-3BD00BF12657Q48152562-79123109-F7A1-4A71-AF27-BAEFD1EF5B7CQ48155513-D0811996-F5B2-4EC9-9CC6-2B41496C85FEQ49109094-F8B09BFB-FF32-4DDF-AB9D-12BFF507E697Q51371295-DD4C8C81-39E7-4AF6-8B4A-44268B777C7AQ53112545-156F539F-843E-4D78-B105-FA0FC0642D65Q54336783-66393EB5-B9AE-4F7A-B13F-FE99F964EB50
P2860
Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@ast
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@en
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@nl
type
label
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@ast
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@en
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@nl
prefLabel
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@ast
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@en
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@nl
P2860
P356
P1476
Differential diagnosis of Park ...... of striatal 18F-dopa PET data
@en
P2093
P2860
P304
P356
10.1136/JNNP.57.3.278
P407
P50
P577
1994-03-01T00:00:00Z